Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon System

<p>Abstract</p> <p>Background</p> <p>Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an antiangiogenic gene transfe...

Full description

Bibliographic Details
Main Authors: Hsu Alice H, Sorenson Brent S, Podetz-Pedersen Kelly M, Belur Lalitha R, Parker Josh B, Carlson Cathy S, Saltzman Daniel A, Ramakrishnan S, McIvor R Scott
Format: Article
Language:English
Published: BMC 2011-02-01
Series:Molecular Cancer
Online Access:http://www.molecular-cancer.com/content/10/1/14
id doaj-eaf275d3247549558f9e2c2b51992d77
record_format Article
spelling doaj-eaf275d3247549558f9e2c2b51992d772020-11-24T22:13:43ZengBMCMolecular Cancer1476-45982011-02-011011410.1186/1476-4598-10-14Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon SystemHsu Alice HSorenson Brent SPodetz-Pedersen Kelly MBelur Lalitha RParker Josh BCarlson Cathy SSaltzman Daniel ARamakrishnan SMcIvor R Scott<p>Abstract</p> <p>Background</p> <p>Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an antiangiogenic gene transfer approach using the <it>Sleeping Beauty </it>(SB) transposon system could be used to inhibit growth of colorectal tumors metastatic to the liver.</p> <p>Results</p> <p>Liver CT26 tumor-bearing mice were hydrodynamically injected with different doses of a plasmid containing a transposon encoding an angiostatin-endostatin fusion gene (Statin AE) along with varying amounts of SB transposase-encoding plasmid. Animals that were injected with a low dose (10 μg) of Statin AE transposon plasmid showed a significant decrease in tumor formation only when co-injected with SB transposase-encoding plasmid, while for animals injected with a higher dose (25 μg) of Statin AE transposon, co-injection of SB transposase-encoding plasmid did not significantly affect tumor load. For animals injected with 10 μg Statin AE transposon plasmid, the number of tumor nodules was inversely proportional to the amount of co-injected SB plasmid. Suppression of metastases was further evident in histological analyses, in which untreated animals showed higher levels of tumor cell proliferation and tumor vascularization than animals treated with low dose transposon plasmid.</p> <p>Conclusion</p> <p>These results demonstrate that hepatic colorectal metastases can be reduced using antiangiogenic transposons, and provide evidence for the importance of the transposition process in mediating suppression of these tumors.</p> http://www.molecular-cancer.com/content/10/1/14
collection DOAJ
language English
format Article
sources DOAJ
author Hsu Alice H
Sorenson Brent S
Podetz-Pedersen Kelly M
Belur Lalitha R
Parker Josh B
Carlson Cathy S
Saltzman Daniel A
Ramakrishnan S
McIvor R Scott
spellingShingle Hsu Alice H
Sorenson Brent S
Podetz-Pedersen Kelly M
Belur Lalitha R
Parker Josh B
Carlson Cathy S
Saltzman Daniel A
Ramakrishnan S
McIvor R Scott
Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon System
Molecular Cancer
author_facet Hsu Alice H
Sorenson Brent S
Podetz-Pedersen Kelly M
Belur Lalitha R
Parker Josh B
Carlson Cathy S
Saltzman Daniel A
Ramakrishnan S
McIvor R Scott
author_sort Hsu Alice H
title Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon System
title_short Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon System
title_full Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon System
title_fullStr Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon System
title_full_unstemmed Inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>Sleeping Beauty </it>Transposon System
title_sort inhibition of angiogenesis and suppression of colorectal cancer metastatic to the liver using the <it>sleeping beauty </it>transposon system
publisher BMC
series Molecular Cancer
issn 1476-4598
publishDate 2011-02-01
description <p>Abstract</p> <p>Background</p> <p>Metastatic colon cancer is one of the leading causes of cancer-related death worldwide, with disease progression and metastatic spread being closely associated with angiogenesis. We investigated whether an antiangiogenic gene transfer approach using the <it>Sleeping Beauty </it>(SB) transposon system could be used to inhibit growth of colorectal tumors metastatic to the liver.</p> <p>Results</p> <p>Liver CT26 tumor-bearing mice were hydrodynamically injected with different doses of a plasmid containing a transposon encoding an angiostatin-endostatin fusion gene (Statin AE) along with varying amounts of SB transposase-encoding plasmid. Animals that were injected with a low dose (10 μg) of Statin AE transposon plasmid showed a significant decrease in tumor formation only when co-injected with SB transposase-encoding plasmid, while for animals injected with a higher dose (25 μg) of Statin AE transposon, co-injection of SB transposase-encoding plasmid did not significantly affect tumor load. For animals injected with 10 μg Statin AE transposon plasmid, the number of tumor nodules was inversely proportional to the amount of co-injected SB plasmid. Suppression of metastases was further evident in histological analyses, in which untreated animals showed higher levels of tumor cell proliferation and tumor vascularization than animals treated with low dose transposon plasmid.</p> <p>Conclusion</p> <p>These results demonstrate that hepatic colorectal metastases can be reduced using antiangiogenic transposons, and provide evidence for the importance of the transposition process in mediating suppression of these tumors.</p>
url http://www.molecular-cancer.com/content/10/1/14
work_keys_str_mv AT hsualiceh inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT sorensonbrents inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT podetzpedersenkellym inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT belurlalithar inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT parkerjoshb inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT carlsoncathys inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT saltzmandaniela inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT ramakrishnans inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
AT mcivorrscott inhibitionofangiogenesisandsuppressionofcolorectalcancermetastatictotheliverusingtheitsleepingbeautyittransposonsystem
_version_ 1725800045983301632